Combination therapy with sirolimus and mycophenolate mofetil: effects on the kidney and on transforming growth factor-??11
Authors:
- Fuad S. ShihabFSFuad S. Shihab
- William M. BennettWBWilliam M. Bennett
- Hong YiHYHong Yi
- Seung-Ok ChoiSCSeung-Ok Choi
- Takeshi F. AndohTATakeshi F. Andoh
- 1 March 2004
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 77 (5) , 683-686
Abstract
Sirolimus (SRL) is not nephrotoxic, but it has been shown to increase transforming growth factor (TGF)-beta. We investigated the effect of combining mycophenolate mofetil (MMF) with SRL on renal structure and function and on TGF-beta1. Rats treated with vehicle (VH), MMF 10 mg/kg/d, SRL 0.3 mg/kg/d, or SRL+MMF were killed at 28 days. The physiologic and histologic changes and expression of TGF-beta1, plasminogen activator inhibitor-1, and extracellular matrix proteins were studied. Although SRL alone did not alter renal function and structure, it increased TGF-beta1 mRNA by 44% and protein by 48% (P <0.05 vs. VH). Treatment with MMF did not affect TGF-beta1. When combined with SRL, MMF decreased TGF-beta1 expression to VH levels. A similar trend was observed with plasminogen activator inhibitor-1 and extracellular matrix proteins. The long-term consequence of increased TGF-beta in SRL-treated kidneys remains unknown. However, because MMF can reverse this trend, SRL and MMF combination therapy may be protective.Keywords
This publication has 9 references indexed in Scilit:
- Mycophenolate Mofetil Ameliorates Arteriolopathy and Decreases Transforming Growth Factor-β1 in Chronic Cyclosporine NephrotoxicityAmerican Journal of Transplantation, 2003
- Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days postkidney transplantation1Transplantation, 2002
- RAPAMYCIN INCREASES TRANSFORMING GROWTH FACTOR-?? mRNA EXPRESSION IN IMMORTALIZED RAT PROXIMAL RENAL TUBULAR CELLSTransplantation, 2002
- Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cellsAmerican Journal of Physiology-Renal Physiology, 2001
- RAPAMYCIN INDUCES TRANSFORMING GROWTH FACTOR-?? PRODUCTION BY LYMPHOCYTES1Transplantation, 2000
- SIROLIMUS (RAPAMYCIN) HALTS AND REVERSES PROGRESSION OF ALLOGRAFT VASCULAR DISEASE IN NON-HUMAN PRIMATES1Transplantation, 2000
- MECHANISM OF THE COMBINATION IMMUNOSUPPRESSIVE EFFECTS OF RAPAMYCIN WITH EITHER CYCLOSPORINE OR TACROLIMUSTransplantation, 2000
- Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidneyKidney International, 2000
- SYNERGISTIC EFFECTS OF CYCLOSPORINE AND RAPAMYCIN IN A CHRONIC NEPHROTOXICITY MODEL1Transplantation, 1996